LifeSan Clinical Research is a full-service clinical research division of Centaur Pharmaceuticals Pvt. Ltd. LifeSan is located in Mumbai, the financial capital of India. LifeSan offers services of bioavailability-bioequivalence studies in male and female Subjects as well as late-phase [phase II, III and IV] clinical trials along with full-fledged statistical services including CDISC datasets.

Since its inception in 2008, LifeSan has faced 9 successful USFDA inspections. Continuing the impeccable track record, the latest USFDA inspection conducted during June 16 to June 20, 2025, was a “clean inspection” meaning no 483 observations, no discussion items and no recommendations. Apart from USFDA, LifeSan is also successfully inspected by EMA, MHRA, SAHPRA, ISP-Chile, NPRA – Malaysia and of course CDSCO, India.

Additionally, studies conducted at LifeSan have also been successfully submitted to TGA [Australia], Health Canada and CIS countries.